Testing a pulse field therapy for reduced heart ischemia
Part of Heart & circulation clinical trials.
This trial studies whether pulse electromagnetic field therapy can improve signs of reduced blood flow to the heart (ischemia) in people who cannot or will not get a coronary procedure during the study. If you already take standard heart medicines, you may be eligible to add this therapy and undergo exercise testing and heart imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You have known heart ischemia and cannot or will not have a coronary procedure during the study (like stents or other interventions).
- Past tests (like an echocardiogram, nuclear scan, or a standard ECG in the last 6 months) showed ischemia.
- Your heart pumping strength is preserved: left ventricular ejection fraction over 40% on an echo done in the last 3 months.
- You can do a supervised exercise test, and any limits are not mainly from orthopedic problems (like severe joint issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests a new procedure called pulsed field ablation for people who have both persistent atrial fibrillation and a type of heart failure (HFpEF). It aims to see if this ablation safely helps control the heart rhythm.
This study tests a new heart scan method to help doctors improve pacemaker treatment for people with heart failure. If you already qualify for a special pacemaker called CRT, this scan may make the treatment work better for you.
This study tests a wearable device that records your heart's electrical activity to help diagnose if you have reduced blood flow to the heart muscle (myocardial ischemia). It may offer a more convenient way to detect heart problems.
This study uses a special imaging test (PET/MR) to check if damaged heart muscle is still alive and can recover. It is for people with severe blocked arteries and weak heart pumping function who are planning bypass surgery or stem cell treatment.
This study collects results from two types of heart imaging—cardiac PET and CardioFlux magnetocardiography—in people with suspected reduced blood flow to the heart. It may help researchers better understand which imaging findings match coronary ischemia and how the tests compare.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.